Tracking the results of drug safety and efficacy
Letter: No European Consensus on Steroid Use in Rheumatoid Arthritis
There is not a consensus between all European rheumatologists regarding the use of steroids in RA; quite a few share your skepticism, including myself.
Drug Updates
Information on new approvals and medication safety.
ACR Issues Guidelines, Recommendations for Lupus Nephritis, RA
Detailed screening and treatment recommendations based on current evidence, extensive literature review.
Minerals, Mud, Martinis, and Methylprednisone
How the practice of rheumatology differs in America and Europe.
Medication Quick Guides Offer Infusion Staff a Streamlined Resource
The ACR/ARHP Medication Quick Guides offer easily accessable pharmaceutical information to rheumatologists.
Drug Updates: Citalopram hydrobromide, Statins, and More
Information on new approvals and medication safety
Treatment Patterns and Trends for Spondylarthropathies
Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.
Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk
Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.
Biosimilar Drugs Face Challenges to Reach the U.S. Market
To date, the FDA has not approved a biosimilar product. In its own discussion of the merits and obstacles to biosimilar drugs, the ACR sponsored a panel session titled, “Biosimilar Products in the U.S. Market: Fact or Fiction?” at the 2011 ACR/ARHP Annual Scientific Meeting here in November.
- « Previous Page
- 1
- …
- 112
- 113
- 114
- 115
- 116
- …
- 120
- Next Page »